Esther Bouman‐Thio
- Immunology top 10%
- Radiology, Nuclear Medicine and Imaging top 10%
- Rheumatology top 5%
- Hematology top 10%
- Molecular Biology
- Co-authors
- Hugh M. DavisHonghui ZhouZhenhua XuJoseph C. MariniPeter J. BugelskiGeorge TreacyRenold J. CapocasaleBart Frederick
- Topics
- Monoclonal and Polyclonal Antibodies Research (8 papers)Chronic Lymphocytic Leukemia Research (4 papers)Immunodeficiency and Autoimmune Disorders (4 papers)
- Cited by
- ImmunologyRheumatologyHematology
- Journals
- Clinical Pharmacology & TherapeuticsClinical PharmacokineticsBritish Journal of Clinical Pharmacology
- Partner nations
- United StatesBelgiumNetherlands
In The Last Decade
Esther Bouman‐Thio
13 papers receiving 642 citations
Peers
Comparison fields: 5 of 75
- Immunology 295
- Radiology, Nuclear Medicine and Imaging 217
- Rheumatology 198
- Hematology 143
- Molecular Biology 135
Countries citing papers authored by Esther Bouman‐Thio
This map shows the geographic impact of Esther Bouman‐Thio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esther Bouman‐Thio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esther Bouman‐Thio more than expected).
Fields of papers citing papers by Esther Bouman‐Thio
This network shows the impact of papers produced by Esther Bouman‐Thio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esther Bouman‐Thio. The network helps show where Esther Bouman‐Thio may publish in the future.
Co-authorship network of co-authors of Esther Bouman‐Thio
This figure shows the co-authorship network connecting the top 25 collaborators of Esther Bouman‐Thio. A scholar is included among the top collaborators of Esther Bouman‐Thio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Esther Bouman‐Thio. Esther Bouman‐Thio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 65 | |
| 2 | 19 | |
| 3 | 17 | |
| 4 | 16 | |
| 5 | 83 | |
| 6 | 32 | |
| 7 | 82 | |
| 8 | 114 | |
| 9 | 31 | |
| 10 | 31 | |
| 11 | 149 | |
| 12 | A phase I study assessing the safety, clinical response, and pharmacokinetics of an experimental infliximab formulation for subcutaneous or intramuscular administration in patients with rheumatoid arthritis. | 17 |
| 13 | 10 |
About Esther Bouman‐Thio
Esther Bouman‐Thio is a scholar working on Genetics, Immunology and Radiology, Nuclear Medicine and Imaging, having authored 13 papers that have together received 666 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (8 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Immunodeficiency and Autoimmune Disorders (4 papers). The work is most often cited by research in Immunology (295 citations), Rheumatology (198 citations) and Hematology (143 citations). Esther Bouman‐Thio has collaborated with scholars based in United States, Belgium and Netherlands. Frequent co-authors include Hugh M. Davis, Honghui Zhou, Zhenhua Xu, Joseph C. Marini, Peter J. Bugelski, George Treacy, Renold J. Capocasale, Bart Frederick, Stanley J. Marciniak and Yanli Zhuang. Their work appears in journals such as Clinical Pharmacology & Therapeutics, Clinical Pharmacokinetics and British Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.